secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001387131-21-007425
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals appoints Carolyn E. Taylor to Board of Directors
----------------------------------------------------------------------

- Carolyn E. Taylor appointed to Board effective July 16, 2021, increasing board size to eight.
- Taylor brings 35+ years of corporate law experience, including partner at Covington & Burling.
- Granted 237,437 stock options vesting at 2022 annual meeting, exercisable at $0.98 per share.
- Will receive annual retainer of $50,000 for board service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713121007425/0001387131-21-007425-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713121007425/tnxp-8k_071621.htm
  HTML page:      https://secwatch.observer/filing/0001387131-21-007425

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer